
| 2019 | |
|---|---|
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Total Project Funding per Partner: | 800-900 |
| Total Number of Projects: | > 1000 |
Total number of projects: 4
As coordinator: 0
As participant: 4
Sole participant: 0
Coordinator / Participant Ratio: 0*
| Total project funding [€]: | Projects [No]: | |||||
|---|---|---|---|---|---|---|
| Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
| 2023 | 0 | 10.401.956 | 243.675 | 1 | ||
| 2022 | 0 | 9.188.294 | 121.615 | 1 | ||
| 2021 | 0 | 2.998.313 | 135.750 | 1 | ||
| 2019 | 0 | 8.603.990 | 1.924.713 | 1 | ||
Total number of partners: 50
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 50
Frequent / Rare Partner Ratio: 0
| Start date | Project | acronym | role | funding | partners |
|---|---|---|---|---|---|
| 2023-01-01 | Building REsilience against MEntal illness during ENDocrine-sensitive life stages | Re-MEND | participant | 10.401.956 | 16 |
| 2022-06-01 | Infectious Disease decision-support tools and Alert systems to build climate Resilience to emerging health Threats | IDAlert | participant | 9.188.294 | 19 |
| 2021-02-01 | Prevention and Screening Innovation Project Towards Elimination of Cervical Cancer | PRESCRIP-TEC | participant | 2.998.313 | 14 |
| 2019-09-01 | Early clinical development of a live, attenuated combination vaccine against Shigella and ETEC diarrhoea | SHIGETECVAX | participant | 8.603.990 | 5 |